litlas
ログインアカウント作成

Yu Shyr

1975–2025 年に発表

269
論文数
48,117
被引用数
115
h 指数
242
i10 指数

被引用数

Yu Shyr の年別被引用数1971 年: 被引用 1 件1975 年: 被引用 1 件1984 年: 被引用 1 件1994 年: 被引用 2 件1995 年: 被引用 8 件1996 年: 被引用 36 件1997 年: 被引用 40 件1998 年: 被引用 61 件1999 年: 被引用 86 件2000 年: 被引用 103 件2001 年: 被引用 135 件2002 年: 被引用 157 件2003 年: 被引用 169 件2004 年: 被引用 196 件2005 年: 被引用 251 件2006 年: 被引用 268 件2007 年: 被引用 277 件2008 年: 被引用 270 件2009 年: 被引用 286 件2010 年: 被引用 272 件2011 年: 被引用 308 件2012 年: 被引用 417 件2013 年: 被引用 455 件2014 年: 被引用 518 件2015 年: 被引用 541 件2016 年: 被引用 533 件2017 年: 被引用 539 件2018 年: 被引用 537 件2019 年: 被引用 1,598 件2020 年: 被引用 1,920 件2021 年: 被引用 1,855 件2022 年: 被引用 1,310 件2023 年: 被引用 913 件2024 年: 被引用 1,342 件2025 年: 被引用 616 件2026 年: 被引用 25 件1972〜1974 年は被引用が無いため表示していません1976〜1983 年は被引用が無いため表示していません1985〜1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 7,135 件、この内訳の 30.3%中国: 引用元論文 2,485 件、この内訳の 10.6%イギリス: 引用元論文 1,412 件、この内訳の 6%イタリア: 引用元論文 1,182 件、この内訳の 5%ドイツ: 引用元論文 1,047 件、この内訳の 4.5%フランス: 引用元論文 783 件、この内訳の 3.3%カナダ: 引用元論文 729 件、この内訳の 3.1%オーストラリア: 引用元論文 651 件、この内訳の 2.8%日本: 引用元論文 644 件、この内訳の 2.7%スペイン: 引用元論文 614 件、この内訳の 2.6%オランダ: 引用元論文 566 件、この内訳の 2.4%スイス: 引用元論文 447 件、この内訳の 1.9%
0%30.3%その他 24.8%

機関

分野

  • Medicine52.8%
  • Biochemistry, Genetics and Molecular Biology31.2%
  • Immunology and Microbiology5.1%
  • Nursing1.8%
  • Chemistry1.5%
  • Computer Science1.3%
  • その他6.3%

トピック

  • Cancer Immunotherapy and Biomarkers3.1%
  • Cancer Genomics and Diagnostics2.4%
  • Cancer Cells and Metastasis2.3%
  • Lung Cancer Treatments and Mutations2.1%
  • Breast Cancer Treatment Studies1.9%
  • Advanced Breast Cancer Therapies1.5%
  • その他86.7%

共著者

全論文

検索で開く
  1. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

    著者: Brian D. Lehmann, Joshua A. Bauer, Xi Chen, Melinda E. Sanders, A. Bapsi Chakravarthy, Yu Shyr, Jennifer A. Pietenpol - Journal of Clinical Investigation 2011 被引用: 5,515

  2. Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

    著者: Brian D. Lehmann, Bojana Jovanović, Xi Chen, Mónica V. Estrada, Kimberly N. Johnson, Yu Shyr, Harold L. Moses, Melinda E. Sanders, Jennifer A. Pietenpol - PLoS ONE 2016 被引用: 1,409

  3. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

    著者: Douglas B. Johnson, Mónica V. Estrada, Roberto Salgado, Violeta Sánchez, Deon B. Doxie, Susan R. Opalenik, Anna E. Vilgelm, Emily Feld, Adam S. Johnson, Allison R. Greenplate, Melinda E. Sanders, Christine M. Lovly, Dennie T. Frederick, Mark C. Kelley, Ann Richmond, Jonathan M. Irish, Yu Shyr, Ryan J. Sullivan, Igor Puzanov, Jeffrey A. Sosman, Justin M. Balko - Nature Communications 2016 被引用: 572

  4. Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    著者: Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, David J. Kwiatkowski, A. John Iafrate, Ignacio I. Wistuba, Marileila Varella‐Garcia, Wilbur A. Franklin, Samuel L. Aronson, Pei-Fang Su, Yu Shyr, D. Ross Camidge, Lecia V. Sequist, Bonnie S. Glisson, Fadlo R. Khuri, Edward B. Garon, William Pao, Charles M. Rudin, Joan H. Schiller, Eric B. Haura, Mark A. Socinski, Keisuke Shirai, Heidi Chen, Giuseppe Giaccone, Marc Ladanyi, Kelly Kugler, John D. Minna, Paul A. Bunn - JAMA 2014 被引用: 1,744

  5. Integrated Omics of Metastatic Colorectal Cancer

    著者: Chen Li, Yidi Sun, Guanyu Yu, Jing-Ru Cui, Zheng Lou, Hang Zhang, Ya Huang, Chen-Guang Bai, Lu-Lu Deng, Peng Liu, Kuo Zheng, Yan-Hua Wang, Qin-Qin Wang, Qingrun Li, Qingqing Wu, Qi Liu, Yu Shyr, Yi-Xue Li, Luo-Nan Chen, Jia-Rui Wu, Wei Zhang, Rong Zeng - Cancer Cell 2020 被引用: 304

  6. DC isoketal-modified proteins activate T cells and promote hypertension

    著者: Annet Kirabo, Vanessa Fontana, Ana Paula de Faria, Roxana Loperena, Cristi L. Galindo, Jing Wu, Alfiya Bikineyeva, Sergey Dikalov, Liang Xiao, Wei Chen, Mohamed A. Saleh, Daniel W. Trott, Hana A. Itani, Antony Vinh, Venkataraman Amarnath, Kalyani Amarnath, Tomasz J. Guzik, Kenneth E. Bernstein, Xiao Z. Shen, Yu Shyr, Sheau‐Chiann Chen, Raymond L. Mernaugh, Cheryl L. Laffer, Fernando Elijovich, Sean S. Davies, Heitor Moreno, Meena S. Madhur, Jackson Roberts, David G. Harrison - Journal of Clinical Investigation 2014 被引用: 533

  7. Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

    著者: Luigi Formisano, Yao Lu, Alberto Servetto, Ariella B. Hanker, Valerie M. Jansen, Joshua A. Bauer, Dhivya R. Sudhan, Ángel Guerrero‐Zotano, Sarah Croessmann, Yan Guo, Paula I. González-Ericsson, Kyung‐min Lee, Mellissa J. Nixon, Luis J. Schwarz, Melinda E. Sanders, Teresa C. Dugger, Marcelo Cruz, Amir Behdad, Massimo Cristofanilli, Aditya Bardia, Joyce O’Shaughnessy, Rebecca J. Nagy, Richard B. Lanman, Nadia Solovieff, Wei He, Michelle C. Miller, Fei Su, Yu Shyr, Ingrid A. Mayer, Justin M. Balko, Carlos L. Arteaga - Nature Communications 2019 被引用: 419

  8. Biomarker Discovery and Validation: Statistical Considerations

    著者: Fang‐Shu Ou, Stefan Michiels, Yu Shyr, Alex A. Adjei, Ann L. Oberg - Journal of Thoracic Oncology 2021 被引用: 232

  9. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

    著者: Yang Li, Laura M. DeBusk, Koari Fukuda, Barbara Fingleton, Brenda Green‐Jarvis, Yu Shyr, Lynn M. Matrisian, David P. Carbone, P. Charles Lin - Cancer Cell 2004 被引用: 1,136

  10. Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib

    著者: Jeffrey A. Sosman, Kevin B. Kim, Lynn M. Schuchter, René González, Anna C. Pavlick, Jeffrey S. Weber, Grant A. McArthur, Thomas E. Hutson, Stergios J. Moschos, Keith T. Flaherty, Peter Hersey, Richard Kefford, Donald P. Lawrence, Igor Puzanov, Karl D. Lewis, Ravi K. Amaravadi, Bartosz Chmielowski, H. Jeffrey Lawrence, Yu Shyr, Fei Ye, Jiang Li, K. B. Nolop, Richard J. Lee, Andrew K. Joe, Antoni Ribas - New England Journal of Medicine 2012 被引用: 2,148

  11. Preoperative and Postoperative Systemic Therapy for Operable Non–Small-Cell Lung Cancer

    著者: Jamie E. Chaft, Yu Shyr, Boris Sepesi, Patrick M. Forde - Journal of Clinical Oncology 2022 被引用: 210

  12. Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer

    著者: Todd W. Miller, Bryan T. Hennessy, Ana M. González-Angulo, Emily M. Fox, Gordon B. Mills, Heidi Chen, Catherine Higham, Carlos Garcı́a-Echeverrı́a, Yu Shyr, Carlos L. Arteaga - Journal of Clinical Investigation 2010 被引用: 545

  13. Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse

    著者: Karinna Almodovar, Wade T. Iams, Catherine B. Meador, Zhiguo Zhao, Sally J. York, Leora Horn, Yingjun Yan, Jennifer Hernandez, Heidi Chen, Yu Shyr, Lee P. Lim, Christopher K. Raymond, Christine M. Lovly - Journal of Thoracic Oncology 2017 被引用: 137

  14. The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor

    著者: Anne E. Powell, Yang Wang, Yina Li, Emily J. Poulin, Anna L. Means, Mary K. Washington, James N. Higginbotham, Alwin M. Juchheim, Nripesh Prasad, Shawn Levy, Yan Guo, Yu Shyr, Bruce J. Aronow, Kevin M. Haigis, Jeffrey L. Franklin, Robert J. Coffey - Cell 2012 被引用: 694

  15. Nationwide Trends in Mastectomy for Early-Stage Breast Cancer

    著者: Kristy L. Kummerow, Liping Du, David F. Penson, Yu Shyr, Mary Hooks - JAMA Surgery 2014 被引用: 727

  16. TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer

    著者: Brian D. Lehmann, Vandana G. Abramson, Melinda E. Sanders, Erica L. Mayer, Tufia C. Haddad, Rita Nanda, Catherine Van Poznak, Anna Maria Storniolo, Julie R. Nangia, Paula I. González-Ericsson, Violeta Sánchez, Kimberly N. Johnson, Richard G. Abramson, Sheau‐Chiann Chen, Yu Shyr, Carlos L. Arteaga, Antonio C. Wolff, Jennifer A. Pietenpol - Clinical Cancer Research 2019 被引用: 154

  17. Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer

    著者: J. Joshua Smith, Natasha G. Deane, Fei Wu, Nipun B. Merchant, Bing Zhang, Aixiang Jiang, Pengcheng Lu, James C. Johnson, Carl Schmidt, Christina E. Bailey, Steven A. Eschrich, Christian Kis, Shawn Levy, M. Kay Washington, Martin J. Heslin, Robert J. Coffey, Timothy J. Yeatman, Yu Shyr, R. Daniel Beauchamp - Gastroenterology 2009 被引用: 730

  18. Improvements and impacts of GRCh38 human reference on high throughput sequencing data analysis

    著者: Yan Guo, Yulin Dai, Hui Yu, Shilin Zhao, David C. Samuels, Yu Shyr - Genomics 2017 被引用: 182

  19. Oligoclonal CD8 + T Cells Play a Critical Role in the Development of Hypertension

    著者: Daniel W. Trott, Salim Thabet, Annet Kirabo, Mohamed A. Saleh, Hana A. Itani, Allison E. Norlander, Jing Wu, Anna E. Goldstein, William J. Arendshorst, Meena S. Madhur, Wei Chen, Chung-I Li, Yu Shyr, David G. Harrison - Hypertension 2014 被引用: 236

  20. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

    著者: Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera, Sanjay Shete, Chih–Yuan Hsu, Aakash Desai, Gilberto Lopes, Petros Grivas, Corrie Painter, Solange Peters, Michael A Thompson, Ziad Bakouny, Gerald Batist, Tanios Bekaii‐Saab, Mehmet Asım Bilen, Nathaniel Bouganim, Mateo Bover Larroya, Daniel Castellano, Salvatore A. Del Prete, Deborah B. Doroshow, Pamela Egan, Arielle Elkrief, Dimitrios Farmakiotis, Daniel Flora, Matthew D. Galsky, Michael Glover, Elizabeth A. Griffiths, Anthony P. Gulati, Shilpa Gupta, Navid Hafez, Þorvarður R. Hálfdánarson, Jessica E. Hawley, Emily Hsu, Anup Kasi, Ali Raza Khaki, Christopher A. Lemmon, Colleen Lewis, Barbara Logan, Tyler Masters, Rana R. McKay, Ruben A. Mesa, Alicia K. Morgans, Mary F. Mulcahy, Orestis A. Panagiotou, Prakash Peddi, Nathan A. Pennell, Kerry L. Reynolds, L Rosen, Rachel Rosovsky, Mary Salazar, Andrew Schmidt, Sumit Shah, Justin Shaya, John A. Steinharter, Keith Stockerl‐Goldstein, Suki Subbiah, Donald C. Vinh, Firas Wehbe, Lisa B. Weissmann, Julie Wu, Elizabeth Wulff‐Burchfield, Zhuoer Xie, Albert C. Yeh, Peter Paul Yu, Alice Y. Zhou, Leyre Zubiri, Sanjay Mishra, Gary H. Lyman, Brian I. Rini, Jeremy L. Warner, Maheen Z. Abidi, Jared D. Acoba, Neeraj Agarwal, Syed A. Ahmad, Archana Ajmera, Jessica K. Altman, Anne H. Angevine, Nilo Azad, Michael Bär, Aditya Bardia, Jill S. Barnholtz‐Sloan, Briana Barrow, Babar Bashir, Rimma Belenkaya, Stephanie Berg, Eric Bernicker, Christine M. Bestvina, Rohit Bishnoi, Genevieve M. Boland, Mark Bonnen, Gabrielle Bouchard, Daniel W. Bowles, Fiona Busser, Angelo Cabal, Paolo F. Caimi, Theresa M. Carducci, Carla Casulo ほか 136 名 - The Lancet 2020 被引用: 1,802

  21. Advanced Heat Map and Clustering Analysis Using Heatmap3

    著者: Shilin Zhao, Yan Guo, Quanhu Sheng, Yu Shyr - BioMed Research International 2014 被引用: 352

  22. Genomic profiling of ER + breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance

    著者: Jennifer M. Giltnane, Katherine E. Hutchinson, Thomas Stricker, Luigi Formisano, Christian D. Young, Mónica V. Estrada, Mellissa J. Nixon, Liping Du, Violeta Sánchez, Paula I. González-Ericsson, María G. Kuba, Melinda E. Sanders, Xinmeng Jasmine Mu, Eliezer M. Van Allen, Nikhil Wagle, Ingrid A. Mayer, Vandana G. Abramson, Henry Gómez, Monica Rizzo, Weiyi Toy, Sarat Chandarlapaty, Erica L. Mayer, Jason Christiansen, Danielle Murphy, Kerry Fitzgerald, Kai Wang, Jeffrey S. Ross, Vincent A. Miller, P. J. Stephens, Roman Yelensky, Levi A. Garraway, Yu Shyr, Ingrid M. Meszoely, Justin M. Balko, Carlos L. Arteaga - Science Translational Medicine 2017 被引用: 124

  23. Plasma cytokine levels predict mortality in patients with acute renal failure

    著者: Edith Simmons, Jonathan Himmelfarb, Mehmet Tuğrul Sezer, Glenn M. Chertow, Ravindra L. Mehta, Emil P. Paganini, Sharon Soroko, S. Freedman, Karen Becker, Daniel Spratt, Yu Shyr, Talp Ikizler, for the PICARD Study Group - Kidney International 2004 被引用: 444

  24. Comparative Treatment Outcomes for Patients With Idiopathic Subglottic Stenosis

    著者: Alexander Gelbard, Catherine Anderson, Lynne D. Berry, Milan R. Amin, Michael S. Benninger, Joel H. Blumin, Jonathan M. Bock, Paul C. Bryson, Paul F. Castellanos, Sheau‐Chiann Chen, Matthew S. Clary, Seth M. Cohen, Brianna K. Crawley, Seth H. Dailey, James J. Daniero, Alessandro de Alarcón, Donald T. Donovan, Eric S. Edell, Dale C. Ekbom, Sara Fernandes‐Taylor, Daniel S. Fink, Ramon A. Franco, C. Gaelyn Garrett, Elizabeth Guardiani, Alexander T. Hillel, Henry T. Hoffman, Norman D. Hogikyan, Rebecca J. Howell, Li‐Ching Huang, Lena K. Hussain, Michael M. Johns, Jan L. Kasperbauer, Sid Khosla, Cheryl Kinnard, Robbi A. Kupfer, Alexander Langerman, Robert J. Lentz, Robert R. Lorenz, David G. Lott, Anne S. Lowery, Samir Makani, Fabien Maldonado, Kyle Mannion, Laura Matrka, Andrew J. McWhorter, Albert L. Meratı, Matthew Mori, James L. Netterville, Karla O’Dell, Julina Ongkasuwan, Gregory N. Postma, Lindsay Reder, Sarah L. Rohde, Brent E. Richardson, Otis B. Rickman, Clark A. Rosen, Michael J. Rutter, Guri Sandhu, Joshua S. Schindler, Glenn Todd Schneider, Rupali N. Shah, Andrew G. Sikora, Robert J. Sinard, Marshall E. Smith, Libby J. Smith, Ahmed M. S. Soliman, Sigríður Sveinsdóttir, Douglas J. Van Daele, David Veivers, Sunil P. Verma, Paul Weinberger, Philip A. Weissbrod, Christopher T. Wootten, Yu Shyr, David O. Francis - JAMA Otolaryngology–Head & Neck Surgery 2019 被引用: 165